GlaxoSmithKline (GSK) has selected St John’s National Academy of Health Sciences as one of the five locations to conduct the trial for the H1N1 vaccine ‘Pandemrix’ in the country. The trial is expected to commence by the month-end.
The details can be read here.
No comments:
Post a Comment